Results 121 to 130 of about 344,170 (326)
A Spatio-Temporal Bayesian Network Classifier for Understanding Visual Field Deterioration [PDF]
, 2005 Progressive loss of the field of vision is characteristic of a number of eye diseases such as glaucoma which is a leading cause of irreversible blindness in the world. Recently, there has been an explosion in the amount of data being stored on patients
Garway-Heath, D +3 more
core
Exosome‐Loaded Contact Lenses: A Novel Approach for Sustained Ocular Drug Delivery
Nano Select, EarlyView.The graphical abstract illustrates the characterization of the exosomes used, the loading technique, and the visual of the lens post‐exosome loading on the eye model. ABSTRACT Drug‐eluting permeable soft contact lenses are sustainable alternatives to traditional ocular drug delivery methods, such as topical eyedrops, ointments, gels, systemic delivery,
Said El Turk +6 more
wiley +1 more source
Do you give neuroprotective/alternative drugs to manage normal tension glaucoma?
Philippine Journal of Ophthalmology, 2019
Nilo Vincent FlorCruz, MD +2 more
doaj
Research progress of nano delivery systems for intraocular pressure lowering drugs
HeliyonGlaucoma is a chronic ocular disease characterized by optic atrophy and visual field defect. The main risk factor for glaucoma onset and progression is elevated intraocular pressure, which is caused by increased aqueous humor outflow resistance ...
Xiaoyu Zhou +7 more
doaj +1 more source
Obesity, EarlyView.ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown
Obesity, EarlyView.ABSTRACT Objective Obesity affects 42% of older adults, with rates continuing to rise. This a complex condition influenced by non‐modifiable as well as modifiable risk factors. The disease can be treated through modifications to diet, physical activity, and behavior and more recently through antiobesity medications (AOMs) and surgery. Treatment must be
Anna Pendrey, Javier Sevilla‐Martir
wiley +1 more source